These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 35543239

  • 1. Prediction of binding affinity of 1,2-diphenyline ketone analogues at adenosine triphosphate binding site of glycogen synthase kinase-3β: a molecular docking and dynamic simulation study.
    Dinakar S, Gurubarath M, Dhananjayan K.
    J Biomol Struct Dyn; 2023 Jul; 41(11):4847-4862. PubMed ID: 35543239
    [Abstract] [Full Text] [Related]

  • 2. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
    Elangovan ND, Dhanabalan AK, Gunasekaran K, Kandimalla R, Sankarganesh D.
    J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
    [Abstract] [Full Text] [Related]

  • 3. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V, Lanfranco M, Summa M, Porceddu PF, Ciampoli M, Margaroli N, Durando L, Garrone B, Ombrato R, Tongiani S, Reggiani A.
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [Abstract] [Full Text] [Related]

  • 4. Discovery of novel and highly potential inhibitors of glycogen synthase kinase 3-beta (GSK-3β) through structure-based pharmacophore modeling, virtual computational screening, docking and in silico ADMET analysis.
    Benghanem S, Mesli F, Fatima Zohra HA, Nacereddine C, Hadjer C, Abdellatif M.
    J Biomol Struct Dyn; 2024 Sep; 42(14):7091-7106. PubMed ID: 37498130
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design, Synthesis and Biological Evaluation of 7-Chloro-9H-pyrimido[4,5-b]indole-based Glycogen Synthase Kinase-3β Inhibitors.
    Andreev S, Pantsar T, Ansideri F, Kudolo M, Forster M, Schollmeyer D, Laufer SA, Koch P.
    Molecules; 2019 Jun 25; 24(12):. PubMed ID: 31242571
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders.
    Iqbal D, Alsaweed M, Jamal QMS, Asad MR, Rizvi SMD, Rizvi MR, Albadrani HM, Hamed M, Jahan S, Alyenbaawi H.
    Biomolecules; 2023 Nov 04; 13(11):. PubMed ID: 38002295
    [Abstract] [Full Text] [Related]

  • 12. Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.
    El Kerdawy AM, Osman AA, Zaater MA.
    J Mol Model; 2019 May 25; 25(6):171. PubMed ID: 31129879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular docking study of GSK-3β interaction with nomilin, kihadanin B, and related limonoids and triterpenes with a furyl-δ-lactone core.
    Vergoten G, Bailly C.
    J Biochem Mol Toxicol; 2022 Sep 25; 36(9):e23130. PubMed ID: 35686814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases.
    Gianferrara T, Cescon E, Grieco I, Spalluto G, Federico S.
    Curr Med Chem; 2022 Sep 25; 29(27):4631-4697. PubMed ID: 35170406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.